Select Bibliography

Filter by any of these (after searching):

CALGB-150705

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 5 items

Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803

Bertagnolli, Monica M. , Niedzwiecki, Donna , Compton, Carolyn C. ... - - J Clin Oncol - 2009

Manuscript - Secondary - Primary - GI - CALGB-150705 , CALGB-89803

p27Kip1 in Stage III Colon Cancer: Implications for Outcome Following Adjuvant Chemotherapy in CALGB 89803

Bertagnolli, Monica M. , Warren, Robert S. , Niedzwiecki, Donna ... - - Clin Cancer Res - 2009

Manuscript - Secondary - Primary - GI - CALGB-150705 , C89803

Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)

Niedzwiecki, Donna , Frankel, Wendy L. , Venook, Alan P. , Ye, Xing ... - - J. Clin. Oncol - 2016

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150705 , C9581

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

Ogino, Shuji , Meyerhardt, Jeffrey A. , Irahara, Natsumi ... - - Clin Cancer Res - 2009

Manuscript - Secondary - Primary - GI - CALGB-150705 , CALGB-89803

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Ogino, Shuji , Shima, Kaori , Meyerhardt, Jeffrey A. ... - - Clin Cancer Res - 2012

Manuscript - Secondary - Primary - GI - CALGB-150705 , C89803